A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults

Maria Llabre, Kathryn E. Weaver, Ron E. Durán, Michael H Antoni, Shvawn McPherson-Baker, Neil Schneiderman

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

This study compared a multiple method measurement model of highly active antiretroviral therapy (HAART) adherence with single-method models to determine optimal validity in predicting HIV viral load. Repeated measures of antiretroviral adherence were collected over a 15-month period using three different measurement methods: a self-report questionnaire, an adherence interview item, and electronic medication monitoring. The participants included HIV-positive men and women (n = 323) who were currently prescribed HAART. Single-factor models composed of multiple measurements over time were developed for each adherence method and HIV viral load. The three adherence methods were then combined in a second order factor measurement model. Structural equation modeling was used to test the models. Mean adherence, defined as percent of doses taken, was 92%, 90%, and 57% by self-report, interview, and electronic monitoring, respectively. Reliability of individual measurements of adherence was low. Four or seven assessments were needed to attain acceptable stability, depending on the method. The second-order factor model of adherence fit the data and explained 45% of the variability in HIV viral load. Models including only one method of assessing adherence explained between 20% and 24% of the variability. Models that included both self-report and electronic monitoring optimized predictive validity. Using at least two different methods of adherence measurement, each assessed at multiple times is recommended to derive reliable and valid measurement of medication adherence, which is predictive of biological outcomes such as HIV viral load.

Original languageEnglish
Pages (from-to)701-711
Number of pages11
JournalAIDS Patient Care and STDs
Volume20
Issue number10
DOIs
StatePublished - Oct 1 2006

Fingerprint

Medication Adherence
Highly Active Antiretroviral Therapy
Viral Load
HIV
Self Report
Interviews

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Leadership and Management
  • Nursing(all)

Cite this

A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults. / Llabre, Maria; Weaver, Kathryn E.; Durán, Ron E.; Antoni, Michael H; McPherson-Baker, Shvawn; Schneiderman, Neil.

In: AIDS Patient Care and STDs, Vol. 20, No. 10, 01.10.2006, p. 701-711.

Research output: Contribution to journalArticle

@article{5468647df50949bc9605f61f13505531,
title = "A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults",
abstract = "This study compared a multiple method measurement model of highly active antiretroviral therapy (HAART) adherence with single-method models to determine optimal validity in predicting HIV viral load. Repeated measures of antiretroviral adherence were collected over a 15-month period using three different measurement methods: a self-report questionnaire, an adherence interview item, and electronic medication monitoring. The participants included HIV-positive men and women (n = 323) who were currently prescribed HAART. Single-factor models composed of multiple measurements over time were developed for each adherence method and HIV viral load. The three adherence methods were then combined in a second order factor measurement model. Structural equation modeling was used to test the models. Mean adherence, defined as percent of doses taken, was 92{\%}, 90{\%}, and 57{\%} by self-report, interview, and electronic monitoring, respectively. Reliability of individual measurements of adherence was low. Four or seven assessments were needed to attain acceptable stability, depending on the method. The second-order factor model of adherence fit the data and explained 45{\%} of the variability in HIV viral load. Models including only one method of assessing adherence explained between 20{\%} and 24{\%} of the variability. Models that included both self-report and electronic monitoring optimized predictive validity. Using at least two different methods of adherence measurement, each assessed at multiple times is recommended to derive reliable and valid measurement of medication adherence, which is predictive of biological outcomes such as HIV viral load.",
author = "Maria Llabre and Weaver, {Kathryn E.} and Dur{\'a}n, {Ron E.} and Antoni, {Michael H} and Shvawn McPherson-Baker and Neil Schneiderman",
year = "2006",
month = "10",
day = "1",
doi = "10.1089/apc.2006.20.701",
language = "English",
volume = "20",
pages = "701--711",
journal = "AIDS Patient Care and STDs",
issn = "1087-2914",
publisher = "Mary Ann Liebert Inc.",
number = "10",

}

TY - JOUR

T1 - A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults

AU - Llabre, Maria

AU - Weaver, Kathryn E.

AU - Durán, Ron E.

AU - Antoni, Michael H

AU - McPherson-Baker, Shvawn

AU - Schneiderman, Neil

PY - 2006/10/1

Y1 - 2006/10/1

N2 - This study compared a multiple method measurement model of highly active antiretroviral therapy (HAART) adherence with single-method models to determine optimal validity in predicting HIV viral load. Repeated measures of antiretroviral adherence were collected over a 15-month period using three different measurement methods: a self-report questionnaire, an adherence interview item, and electronic medication monitoring. The participants included HIV-positive men and women (n = 323) who were currently prescribed HAART. Single-factor models composed of multiple measurements over time were developed for each adherence method and HIV viral load. The three adherence methods were then combined in a second order factor measurement model. Structural equation modeling was used to test the models. Mean adherence, defined as percent of doses taken, was 92%, 90%, and 57% by self-report, interview, and electronic monitoring, respectively. Reliability of individual measurements of adherence was low. Four or seven assessments were needed to attain acceptable stability, depending on the method. The second-order factor model of adherence fit the data and explained 45% of the variability in HIV viral load. Models including only one method of assessing adherence explained between 20% and 24% of the variability. Models that included both self-report and electronic monitoring optimized predictive validity. Using at least two different methods of adherence measurement, each assessed at multiple times is recommended to derive reliable and valid measurement of medication adherence, which is predictive of biological outcomes such as HIV viral load.

AB - This study compared a multiple method measurement model of highly active antiretroviral therapy (HAART) adherence with single-method models to determine optimal validity in predicting HIV viral load. Repeated measures of antiretroviral adherence were collected over a 15-month period using three different measurement methods: a self-report questionnaire, an adherence interview item, and electronic medication monitoring. The participants included HIV-positive men and women (n = 323) who were currently prescribed HAART. Single-factor models composed of multiple measurements over time were developed for each adherence method and HIV viral load. The three adherence methods were then combined in a second order factor measurement model. Structural equation modeling was used to test the models. Mean adherence, defined as percent of doses taken, was 92%, 90%, and 57% by self-report, interview, and electronic monitoring, respectively. Reliability of individual measurements of adherence was low. Four or seven assessments were needed to attain acceptable stability, depending on the method. The second-order factor model of adherence fit the data and explained 45% of the variability in HIV viral load. Models including only one method of assessing adherence explained between 20% and 24% of the variability. Models that included both self-report and electronic monitoring optimized predictive validity. Using at least two different methods of adherence measurement, each assessed at multiple times is recommended to derive reliable and valid measurement of medication adherence, which is predictive of biological outcomes such as HIV viral load.

UR - http://www.scopus.com/inward/record.url?scp=33846425781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846425781&partnerID=8YFLogxK

U2 - 10.1089/apc.2006.20.701

DO - 10.1089/apc.2006.20.701

M3 - Article

VL - 20

SP - 701

EP - 711

JO - AIDS Patient Care and STDs

JF - AIDS Patient Care and STDs

SN - 1087-2914

IS - 10

ER -